|
| 1,2,4-Triazolo[4,3-a]pyrimidine-6-acetamide, N-[5-[(2-fluorophenyl)methyl]-2-thiazolyl]-1,5-dihydro-3,7-dimethyl-5-oxo- Basic information |
Product Name: | 1,2,4-Triazolo[4,3-a]pyrimidine-6-acetamide, N-[5-[(2-fluorophenyl)methyl]-2-thiazolyl]-1,5-dihydro-3,7-dimethyl-5-oxo- | Synonyms: | 1,2,4-Triazolo[4,3-a]pyrimidine-6-acetamide, N-[5-[(2-fluorophenyl)methyl]-2-thiazolyl]-1,5-dihydro-3,7-dimethyl-5-oxo-;HPK1-IN-8 | CAS: | 1214561-09-7 | MF: | C19H17FN6O2S | MW: | 412.44 | EINECS: | | Product Categories: | | Mol File: | 1214561-09-7.mol | |
| 1,2,4-Triazolo[4,3-a]pyrimidine-6-acetamide, N-[5-[(2-fluorophenyl)methyl]-2-thiazolyl]-1,5-dihydro-3,7-dimethyl-5-oxo- Chemical Properties |
density | 1.53±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | pka | 8.27±0.50(Predicted) |
| 1,2,4-Triazolo[4,3-a]pyrimidine-6-acetamide, N-[5-[(2-fluorophenyl)methyl]-2-thiazolyl]-1,5-dihydro-3,7-dimethyl-5-oxo- Usage And Synthesis |
Biological Activity | HPK1-IN-8 is an allosteric, inactive conformation-selective inhibitor of full-length HPK1. | References | [1]. Wang W, et al. Discovery of an Allosteric, Inactive Conformation-Selective Inhibitor of Full-Length HPK1 Utilizing a Kinase Cascade Assay. Biochemistry. 2021 Oct 19;60(41):3114-3124. |
| 1,2,4-Triazolo[4,3-a]pyrimidine-6-acetamide, N-[5-[(2-fluorophenyl)methyl]-2-thiazolyl]-1,5-dihydro-3,7-dimethyl-5-oxo- Preparation Products And Raw materials |
|